Search

David M Fabrizio

from Winston Salem, NC
Age ~65
Get Report
Also known as:
David Michael Fabrizio, Dave M Fabrizio, David Hodos, David Fabrizo
Phone and address:
840 Madison Ave, Winston Salem, NC 27103
(336) 725-8939
Related to:
Kelley A Dumont, 28
Connected to:
Albertina T Fabrizi, 92Andrea E Fabrizi, 59Certo Fabrizio, 59Cheryl Fabrizio, 56Deane L Fabrizio, 69Fe Fabrizio, 57Genevieve Fabrizi, 96Giovannina Fabrizio, 86Jonathan P Fabrizio, 35Kevin A Fabrizi, 35

David Fabrizio Phones & Addresses

  • 840 Madison Ave, Winston Salem, NC 27103 (336) 725-8939
  • 4406 Lazyriver Dr, Durham, NC 27712 (919) 471-2503
  • 10 Planters Wood Trl, Greensboro, NC 27407 (336) 315-8797
  • 3013 Cottage Pl, Greensboro, NC 27455
  • Carrboro, NC
  • Peabody, MA
  • San Antonio, TX

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Associate degree or higher

Languages

English

Industries

Information Technology and Services

Specialities

Nurse Anesthesiology

Professional Records

Medicine Doctors

David Fabrizio Photo 1

David M Fabrizio, Winston Salem NC - CRNA (Certified registered nurse anesthetist)

View page
Specialties:
Nurse Anesthesiology
Address:
145 Kimel Park Dr Suite 300, Winston Salem, NC 27103
(336) 768-3212 (Phone), (336) 768-9019 (Fax)
Languages:
English

Resumes

Resumes

David Fabrizio Photo 2

Director Of Marketing At Ner Data Products

View page
Location:
Greensboro/Winston-Salem, North Carolina Area
Industry:
Information Technology and Services

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Fabrizio
Manager
Edgil Associates Inc
Computer & Software Stores
6 Fortune Dr, Billerica, MA 01821
(978) 262-9799, (978) 667-6050
David Fabrizio
Assistant Principal
Town of North Andover
Elementary/Secondary School
2 Cypress Ter, North Andover, MA 01845
(978) 794-1990
David Fabrizio
Assistant Principal
North Andover Middle School
Computer Software · Elementary/Secondary School · Police Protection · Fire Protection · School/Educational Services · Water Supply Service Sewerage System Irrigation System · Executive Office · Council of Aging
495 Main St, North Andover, MA 01845
1600 Osgood St, North Andover, MA 01845
43 High St, North Andover, MA 01845
1475 Osgood St, North Andover, MA 01845
(978) 794-1503, (978) 683-3168, (978) 794-1711, (978) 688-9590

Publications

Us Patents

Targeted Therapeutics Based On Engineered Proteins That Bind Egfr

View page
US Patent:
8524244, Sep 3, 2013
Filed:
Feb 10, 2009
Appl. No.:
12/867406
Inventors:
Ray Camphausen - Wayland MA, US
Brent Morse - Newton Center MA, US
Stuart Emanuel - Doylestown PA, US
David Fabrizio - Swampscott MA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/17
A61K 38/39
A61K 47/48
C07K 14/71
C07K 14/435
US Classification:
4241851, 4241931, 42419511, 514 93, 514 192, 530350, 530402
Abstract:
The present invention relates to single domain proteins that bind to epidermal growth factor receptor (EGFR). The invention also relates to single domain proteins for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.

Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-Ir

View page
US Patent:
20100121033, May 13, 2010
Filed:
Nov 21, 2007
Appl. No.:
12/312725
Inventors:
Ray Camphausen - Wayland MA, US
David Fabrizio - Swampscott MA, US
Martin C. Wright - Boston MA, US
Patrick Gage - Bala Cynwyd PA, US
John Mendlein - Scituate MA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 14/765
C07K 14/00
C07K 16/00
C07K 14/79
US Classification:
530363, 530350, 5303873, 5303911, 530394
Abstract:
The present invention provides innovative proteins that bind to insulin-like growth factor-I receptor (IGF-IR), as well as other important proteins. The invention also provides innovative proteins in pharmaceutical preparations and derivatives of such proteins and the uses of same in diagnostic, research and therapeutic applications. The invention further provides cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and vectors comprising the polynucleotides encoding the innovative proteins.

Serum Albumin Binding Molecules

View page
US Patent:
20110305663, Dec 15, 2011
Filed:
May 2, 2011
Appl. No.:
13/098851
Inventors:
Michael L. Gosselin - Boston MA, US
David Fabrizio - Swampscott MA, US
Joanna F. Swain - Concord MA, US
Tracy Mitchell - Billerica MA, US
Ray Camphausen - Wayland MA, US
Sharon T. Cload - Cambridge MA, US
Eric Furfine - Concord MA, US
Paul E. Morin - Pennington NJ, US
Ranjan Mukherjee - Churchville PA, US
Simeon I. Taylor - Skillman NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/20
C07K 19/00
A61K 38/17
A61P 3/10
A61P 3/04
A61K 38/18
A61K 38/28
A61K 38/22
A61K 38/26
C07H 21/00
C12N 15/63
C12N 5/10
C12N 1/21
A61P 3/00
A61P 3/06
A61P 9/00
C07K 14/47
US Classification:
424 852, 530324, 530350, 530399, 530351, 514 11, 514 69, 514 48, 514 91, 514 59, 514 88, 514 52, 514 72, 514 117, 514 97, 536 235, 4353201, 435325, 4352523
Abstract:
The present invention relates to an antibody-like protein based on the tenth fibronectin type III domain (Fn3) that binds to serum albumin. The invention further relates to fusion molecules comprising a serum albumin-binding Fn3 joined to a heterologous protein for use in diagnostic and therapeutic applications.

Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-Ir

View page
US Patent:
20130310317, Nov 21, 2013
Filed:
May 13, 2013
Appl. No.:
13/892418
Inventors:
Bristol-Myers Squibb Company - , US
David FABRIZIO - South Hamilton MA, US
Martin C. WRIGHT - Belmont MA, US
Patrick GAGE - Bryn Mawr PA, US
John MENDLEIN - Encinitas CA, US
Assignee:
BRISTOL-MYERS SQUIBB COMPANY - Princeton NJ
International Classification:
A61K 38/18
C07K 16/00
C07K 14/79
C07K 14/00
C07K 14/765
US Classification:
514 87, 530324, 530363, 530394, 5303873, 514 213, 536 231, 4353201
Abstract:
The present invention provides innovative proteins that bind to insulin-like growth factor-I receptor (IGF-IR), as well as other important proteins. The invention also provides innovative proteins in pharmaceutical preparations and derivatives of such proteins and the uses of same in diagnostic, research and therapeutic applications. The invention further provides cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and vectors comprising the polynucleotides encoding the innovative proteins.

Targeted Therapeutics Based On Engineered Proteins That Bind Egfr

View page
US Patent:
20140038893, Feb 6, 2014
Filed:
Aug 1, 2013
Appl. No.:
13/956952
Inventors:
Brent MORSE - Newton MA, US
Stuart EMANUEL - Doylestown PA, US
David FABRIZIO - South Hamilton MA, US
Assignee:
BRISTOL-MYERS SQUIBB COMPANY - Princeton NJ
International Classification:
C07K 14/78
C07K 19/00
C07K 14/79
C07K 14/765
US Classification:
514 93, 530324, 536 235, 530350, 530363, 5303873, 530394
Abstract:
The present invention relates to single domain proteins that bind to epidermal growth factor receptor (EGFR). The invention also relates to single domain proteins for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.

Serum Albumin-Binding Fibronectin Type Iii Domains

View page
US Patent:
20220204589, Jun 30, 2022
Filed:
Nov 16, 2021
Appl. No.:
17/527238
Inventors:
- Princeton NJ, US
Michael L. Gosselin - Boston MA, US
Dasa Lipovsek - Pepperell MA, US
Rex Parker - Titusville NJ, US
Ray Camphausen - Wayland MA, US
Jonathan H. Davis - Madison WI, US
David Fabrizio - South Hamilton MA, US
International Classification:
C07K 14/78
A61K 47/64
Abstract:
The present invention relates to polypeptides which include tenth fibronectin type III domains (Fn3) that binds to serum albumin, with south pole loop substitutions. The invention further relates to fusion molecules comprising a serum albumin-binding Fn3 joined to a heterologous protein for use in diagnostic and therapeutic applications.

Targeted Therapeutics Based On Engineered Proteins That Bind Egfr

View page
US Patent:
20210040181, Feb 11, 2021
Filed:
Aug 19, 2020
Appl. No.:
16/997282
Inventors:
- Princeton NJ, US
Brent MORSE - Newton MA, US
Stuart EMANUEL - Doylestown PA, US
David FABRIZIO - South Hamilton MA, US
International Classification:
C07K 14/78
C07K 16/28
C07K 14/765
C07K 14/79
C07K 19/00
Abstract:
The present invention relates to single domain proteins that bind to epidermal growth factor receptor (EGFR). The invention also relates to single domain proteins for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.

Serum Albumin-Binding Fibronectin Type Iii Domains

View page
US Patent:
20200048328, Feb 13, 2020
Filed:
Aug 23, 2019
Appl. No.:
16/549462
Inventors:
- PRINCETON NJ, US
Michael L. GOSSELIN - Boston MA, US
Dasa LIPOVSEK - Cambridge MA, US
Rex PARKER - Titusville NJ, US
Ray CAMPHAUSEN - Wayland MA, US
Jonathan DAVIS - Auburndale MA, US
David FABRIZIO - South Hamilton MA, US
International Classification:
C07K 14/78
A61K 47/64
Abstract:
The present invention relates to polypeptides which include tenth fibronectin type III domains (Fn3) that binds to serum albumin, with south pole loop substitutions. The invention further relates to fusion molecules comprising a serum albumin-binding Fn3 joined to a heterologous protein for use in diagnostic and therapeutic applications.
Control profile
David M Fabrizio from Winston Salem, NC, age ~65 Get Report